VIP152
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VIP152, covering 2024-11-15 to 2024-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer [Phase 1]